Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Manipulating MicroRNA Levels May Return Cancer Cells to Normalcy

By LabMedica International staff writers
Posted on 07 Sep 2015
A possible approach for inducing cancer cells to revert to a precancerous state is based on the protein PLEKHA7 (Pleckstrin homology domain-containing family A member 7), which regulates the levels of select microRNAs (miRNAs) to suppress expression of cell transforming factors.

Investigators at the Mayo Clinic (Jacksonville, FL, USA) had been trying to explain why two proteins, E-cadherin and p120 catenin (catenin [cadherin-associated protein], delta 1 or p120) sometimes seemed to suppress cancer formation and at other times seemed to promote it.

Cadherins (named for “calcium-dependent adhesion”) are a class of type-1 transmembrane proteins. More...
They play important roles in cell adhesion, ensuring that cells within tissues are bound together. They are dependent on calcium (Ca2+) ions to function, hence their name. Loss of E-cadherin function or expression has been implicated in cancer progression and metastasis. E-cadherin downregulation decreases the strength of cellular adhesion within a tissue, resulting in an increase in cellular motility. This in turn may allow cancer cells to cross the basement membrane and invade surrounding tissues.

The gene for p120 encodes a member of the Armadillo protein family, which function in adhesion between cells and signal transduction.

The investigators reported in the August 24, 2015, online edition of the journal Nature Cell Biology that PLEKHA7 recruited the so-called "microprocessor complex" (association of DROSHA and DGCR8 proteins) to a growth-inhibiting site (apical zonula adherens) in epithelial cells instead of sites at basolateral areas of cell–cell contact. If the microprocessor complex was recruited to a basolateral area instead of to the apical zonula adherens, miRNA regulation was disrupted, causing tumor growth. Restoring normal miRNA levels in tumor cells reversed that aberrant cell growth.

"We believe that loss of the apical PLEKHA7-microprocessor complex is an early and somewhat universal event in cancer," said senior author Dr. Panos Anastasiadis, chairman of the department of cancer biology at the Mayo Clinic. "In the vast majority of human tumor samples we examined, this apical structure is absent, although E-cadherin and p120 are still present. This produces the equivalent of a speeding car that has a lot of gas (the bad p120) and no brakes (the PLEKHA7-microprocessor complex). By administering the affected miRNAs in cancer cells to restore their normal levels, we should be able to reestablish the brakes and restore normal cell function. Initial experiments in some aggressive types of cancer are indeed very promising."

Related Links:

Mayo Clinic



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Automatic CLIA Analyzer
Shine i6000
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: Spatial profiling of muscle-invasive bladder cancer reveals how distinct tumor cell states are organized within individual tumors (Image Credit: Shutterstock)

Spatial Map Guides Treatment Selection in Muscle-Invasive Bladder Cancer

Muscle-invasive bladder cancer is clinically heterogeneous, with patients often responding very differently to therapy. Existing biomarkers do not fully explain these disparities, limiting precision treatment... Read more

Microbiology

view channel
Image: Burkholderia pseudomallei is a soil-dwelling bacterium that causes melioidosis, a severe and potentially fatal infection that remains difficult to diagnose (Image Credit: Gavin Koh/Wikimedia Commons, CC BY-SA 4.0)

Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread

Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.